Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 512 (RNA5SP512)

Target
RNA5SP512
Molecular classification
Pseudogene, processed pseudogene, rRNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 512 (RNA5SP512) is a **processed pseudogene** derived from the 5S ribosomal RNA (5S rRNA) gene[2][6][4]. Pseudogenes are segments of DNA that resemble functional genes but are usually nonfunctional due to mutations, deletions, or insertions acquired over evolutionary time[4][6]. Processed pseudogenes are typically formed by the reverse transcription and integration of RNA transcripts, leading to DNA copies lacking introns and native regulatory sequences[4][6]. The parent 5S rRNA gene encodes a short (~120 nucleotide) RNA that is essential for ribosome structure and function, but pseudogenes of 5S rRNA such as RNA5SP512 do **not produce functional RNA** and *do not participate in ribosome assembly or cellular translation*[5][1][3]. Pseudogenes may occasionally be transcribed, and emerging data suggest that some pseudogene transcripts may have regulatory roles or be used as research biomarkers, including in cancer subtyping, but there is no evidence that RNA5SP512 is a therapeutic target or has direct effects on biological pathways[8]. RNA5SP512 and similar entries are cataloged in gene databases like NCBI Gene and Ensembl, primarily for reference and annotation purposes[2][7]. There is no direct association with therapeutic intervention, direct disease role, or drug interaction.

Other names
RN5S512RNA, 5S ribosomal 512RNA5SP512
02

Disease associations

Possible involvement as a biomarker or in gene regulation (see description), but no direct disease association
03

Biomarkers

Expression in molecular subtyping of cancers

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 512 (RNA5SP512).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 512 (RNA5SP512).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call